The efficacy of alarm therapy versus desmopressin therapy in the treatment of primary mono-symptomatic nocturnal enuresis: a systematic review [PDF]
Nina Perrin, Lynn Sayer, Alison While
openalex +1 more source
PB0268 Desmopressin Response May Fail in Children with Congenital Platelet Function Defects
Eline Huisman +4 more
openalex +1 more source
Desmopressin in the diagnosis and treatment of central diabetes insipidus
Ekaterina Pigarova
openalex +2 more sources
Efficacy & safety of Desmopressin in the treatment of pediatric nocturnal enuresis
Back ground: primary nocturnal enuresis (PNE) is a socially distressing condition that can be troubling for children & their families. It affects 15-26% of five years olds.
Ala’a Al-Deen
doaj
Failure of desmopressin to lower serum sodium or prevent crisis in patients with sickle cell anemia [PDF]
Samuel Charache, WG Walker
openalex +1 more source
Hemostatic evaluation of rabbits envenomed with Bothrops alternatus treated with anti-bothropic serum, desmopressin and tranexamin acid [PDF]
Warley Gomes dos Santos +6 more
openalex +1 more source
Interstitial granulomatous drug reaction after intranasal desmopressin administration
Vincenzo Maione +3 more
openalex +1 more source
PO39 | Bleeding events in Von Willebrand disease type 1 yearly treatable with desmopressin
Background and Aims: Subcutaneous and intranasal desmopressin is safe and effective in type 1 VWD, and particularly convenient for pediatric use and home treatment.
doaj +1 more source

